Showing 21 - 40 results of 132 for search '"lung transplant"', query time: 0.07s Refine Results
  1. 21

    Effect of Maintenance Azithromycin on Established Bronchiolitis Obliterans Syndrome in Lung Transplant Patients by Nancy R Porhownik, Wael Batobara, Wayne Kepron, Helmut W Unruh, Zoheir Bshouty

    Published 2008-01-01
    “…BACKGROUND: Bronchiolitis obliterans syndrome (BOS), the main cause of late mortality following lung transplantation, is defined as an irreversible decline in forced expiratory volume in 1 s (FEV1).Previous studies using azithromycin for BOS in lung transplant patients have demonstrated a potential reversibility of the decline in FEV1.…”
    Get full text
    Article
  2. 22

    Antibody-Mediated Rejection and Sponge Effect in a Redo Lung Transplant Recipient by Ashwini Arjuna, Michael T. Olson, Sofya Tokman, Rajat Walia, Thalachallour Mohanakumar, A. Samad Hashimi, Michael A. Smith, Ross M. Bremner, Ashraf Omar

    Published 2021-01-01
    “…Long-term survival after lung transplant remains severely limited by chronic lung allograft dysfunction. …”
    Get full text
    Article
  3. 23

    Incidence of Fractures after Cardiac and Lung Transplantation: A Single Center Experience by Aileen Hariman, Charles Alex, Alain Heroux, Pauline Camacho

    Published 2014-01-01
    “…Fracture rates up to 35% have been previously reported following heart and lung transplantations. Our institutional pretransplant protocols include DXA scans, vitamin D screening, and appropriate antiresorptive therapy. …”
    Get full text
    Article
  4. 24
  5. 25
  6. 26
  7. 27
  8. 28
  9. 29
  10. 30

    Invasive Microascus trigonosporus Species Complex Pulmonary Infection in a Lung Transplant Recipient by Kelly E. Schoeppler, Martin R. Zamora, Noelle M. Northcutt, Gerard R. Barber, Gayle O’Malley-Schroeder, Dennis M. Lyu

    Published 2015-01-01
    “…Here we present a rare case of invasive infection caused by Microascus trigonosporus species complex in a human, which developed during voriconazole prophylaxis in a lung transplant recipient. Nebulized liposomal amphotericin B was used in addition to systemic therapy in order to optimize antifungal drug exposure; this regimen appeared to reduce the patient’s fungal burden. …”
    Get full text
    Article
  11. 31
  12. 32
  13. 33

    Treatment of Cytomegalovirus Infection with Cidofovir and CMV Immune Globulin in a Lung Transplant Recipient by Heinrike Wilkens, Martina Sester

    Published 2016-01-01
    “…Cytomegalovirus (CMV) infection after lung transplantation is associated with increased risk for pneumonitis and bronchiolitis obliterans as well as allograft rejection and opportunistic infections. …”
    Get full text
    Article
  14. 34
  15. 35

    Analysis of Optimal Health-Related Quality of Life Measures in Patients Waitlisted for Lung Transplantation by Junko Tokuno, Toyofumi F Chen-Yoshikawa, Toru Oga, Takahiro Oto, Tomoyo Okawa, Yoshinori Okada, Miki Akiba, Masaki Ikeda, Daisuke Nakajima, Masatsugu Hamaji, Hideki Motoyama, Akihiro Aoyama, Maki Isomi, Kazuo Chin, Hiroshi Date

    Published 2020-01-01
    “…Improving health-related quality of life (HRQL) is an important goal of lung transplantation, and St. George’s Respiratory Questionnaire (SGRQ) is frequently used for assessing HRQL in patients waitlisted for lung transplantation. …”
    Get full text
    Article
  16. 36
  17. 37

    Continuous Erector Spinae Plane Block for Analgesia after Thoracotomy for Lung Transplantation in an Anticoagulated Patient by Mark Mudarth, Veena Satyapriya, John Coffman, Peter DeSocio, Alec Lawrence, Shana Schwartz, Michael Kushelev

    Published 2021-01-01
    “…Lung transplant recipients are at particular high risk for postoperative respiratory failure as a result of poorly controlled pain, inadequate graft expansion, decreased cough, and reliance on systemic opioid therapy. …”
    Get full text
    Article
  18. 38

    Pre-Anesthesia Extracorporeal Membrane Oxygenation in Two Lung Transplant Recipients with Severe Pulmonary Hypertension by Liu Minqiang, Gao Hong, Chen Jingyu, Wang Yanjuan, Xu Bo, Wang Guilong, Wu Qiang, Hu Chunxiao

    Published 2020-01-01
    “…Extracorporeal membrane oxygenation (ECMO) is a widely used cardiopulmonary support method that is usually implemented after anesthesia during the period of lung transplantation (LTx). In severe pulmonary arterial hypertension (PAH) patients, however, anesthesia induction is a high-risk phase and can result in severe cardiorespiratory failure. …”
    Get full text
    Article
  19. 39

    Role of Mast Cells and Type 2 Innate Lymphoid (ILC2) Cells in Lung Transplantation by Esmaeil Mortaz, Saeede Amani, Sharon Mumby, Ian M. Adcock, Mehrnaz Movassaghi, Jelle Folkerts, Johan Garssen, Gert Folkerts

    Published 2018-01-01
    “…This paper outlines the current understanding of the role of MCs in lung transplantation, with a specific focus on their interaction with ILC2 cells within the engrafted organ.…”
    Get full text
    Article
  20. 40

    Integrated Analysis and Validation of Ferroptosis-Related Genes Associated with Ischemia/Reperfusion Injury in Lung Transplantation by Li Q, Yin J, Lin Q, He J, Shi X, Nie H

    Published 2025-01-01
    “…This study aims to explore the role of ferroptosis in lung transplantation-related ischemia/reperfusion injury and to identify its potential molecular mechanisms through bioinformatics analysis.Methods: Transcriptome data from lung transplant patients were obtained from the Gene Expression Omnibus (GEO) database. …”
    Get full text
    Article